Nucleic acid probes

• US 5,093,232 A
• Filed: 12/23/1986
• Issued: 03/03/1992
• Est. Priority Date: 12/11/1985
• Status: Expired due to Term

• Current Assignee: Chiron Corporation (Bayer AG)
• Original Assignee: Chiron Corporation (Bayer AG)
• Inventors: Urdea, Michael S., Horn, Thomas
• Primary Examiner(s): Kepplinger, Esther L.
• Assistant Examiner(s): Spiegel, Carol A.
• Application Number:
  US07/945,876
• Time in Patent Office: 1,897 Days
• Field of Search: 435/6, 435/7.5, 435/188, 536/23, 536/29, 536/27, 536/26, 536/28, 935/77, 935/78
• US Class Current: 435/6.12
• CPC Class Codes: C07H 19/06 Pyrimidine radicals
• CPC Class Codes: C07H 19/10 with the saccharide radical esterified by phosphoric or polyphosphoric acids
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6813 Hybridisation assays
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 1/706 for hepatitis
• CPC Class Codes: Y02P 20/55 Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Modified nucleotides are provided which have the structure ##STR1## wherein R¹ is a reactive group derivatizable with a detectable label, R² is an optional linking moiety including an amide, thioether or disulfide linkage or a combination thereof, R³ is hydrogen, methyl, bromine, fluorine or iodine, R⁴ is hydrogen, an acid-sensitive, base-stable blocking group of an acyl capping group, R⁵ is hydrogen or a phosphorus derivative, R⁶ is H, OH, or OR where R is a protecting group and x is an integer in the range of 1 and 8 inclusive. Methods of synthesizing the derivatizable nucleotide are disclosed, as are labeled polynucleotide probes prepared therefrom.

Claims

1. A modified nucleotide having the structure ##STR22## wherein:

R¹ is a protected or unprotected --NH₂, --COOH or --SH group;

R² is a covalent bond or an amide linking moiety with the priviso that the amide linkage is oriented --NH--C(═

O)--;

R³ is hydrogen, methyl, bromine, fluorine or iodine;

R⁴ is selected from the group consisting of hydrogen, acid-sensitive, base-stable blocking groups and acyl capping groups;

R⁵ is a phosphorus derivative selected from the group consisting of PO₃ H₂, phosphotriesters, phosphodiesters, phosphites, phosphoramidites, H-phosphonates and phosphorothioates;

R⁶ is H, OH, or OR where R is an acid-sensitive, base-stable protecting group; and

x is an integer in the range of 1 and 8 inclusive,

wherein the nucleotide may bound through R⁵ to a solid support.

2. The modified nucleotide of claim 1 which has the structure ##STR23## wherein the subscripts "x" are each independently integers in the range of 1 and 8 inclusive.

3. The modified nucleotide of claim 2, wherein R¹ is a protected or unprotected --NH₂ group.

4. The modified nucleotide of claim 3, wherein R⁴ and R⁶ are hydrogen.

5. The modified nucleotide of claim 1 given by the structure ##STR24##

6. The modified nucleotide of claim 1 covalently bound to a detectable label through said R¹ moiety.

7. The modified nucleotide of claim 6, wherein said detectable label comprises horseradish peroxidase.

8. The modified nucleotide of claim 6, wherein said detectable label comprises biotin.

9. The modified nucleotide of claim 8 bound via biotin-avidin interaction to a support coated with avidin.

10. The modified nucleotide of claim 6, wherein said detectable label comprises a fluorescent moiety.

11. The modified nucleotide of claim 10, wherein said fluorescent moiety comprises fluorescein.

12. The modified nucleotide of claim 1, wherein R¹ is a protected or unprotected --NH₂ group.

13. The modified nucleotide of claim 12, wherein R⁴ and R⁶ are hydrogen.

14. A method of detecting a polynucleotide analyte in a sample, comprising the sequential steps of:

rendering any double-stranded polynucleotides in said sample single-stranded;

contacting said sample with a polynucleotide probe containing a plurality of modified nucleotides according to claim 1 incorporated at predetermined, spaced apart positions, and having a nucleotide sequence complementary to a predetermined sequence in said analyte such that said probe will hybridize to said analyte, wherein said contacting is for a time sufficient for labeled nucleic acid complexes to form between said probe and said analyte;

isolating any such labeled nucleic acid complexes; and

detecting the presence of said labeled nucleic acid complexes to indicate the presence of said polynucleotide analyte.